2型糖尿病脑葡萄糖动力学的可逆性
研究纳入8例血糖控制不佳的2型糖尿病患者,在4特斯拉下进行高血糖钳夹期间用1H磁共振波谱测量脑葡萄糖。经12周干预改善血糖控制后,HbA1c下降24.3 mmol/mol,脑葡萄糖水平较高血糖钳夹期间显著升高,且脑葡萄糖升高幅度与HbA1c改善程度相关。
要点
- 8例控制不佳的2型糖尿病患者接受12周强化干预后HbA1c平均下降24.3 mmol/mol(p=0.006)。
- 干预后高血糖钳夹期间脑葡萄糖水平较干预前显著升高(p<0.001),而血浆葡萄糖相似(p=0.266)。
- 脑葡萄糖升高幅度与HbA1c改善程度相关(r=0.71,p=0.048)。
核心结论
- 研究结果提示,2型糖尿病患者在血糖控制改善后,脑葡萄糖转运能力和代谢可能具有可逆性。
研究设计与样本
- 8例(2男6女)血糖控制不佳的2型糖尿病患者,平均±SD年龄44.8±8.3岁,BMI 31.4±6.1 kg/m2,HbA1c 84.1±16.2 mmol/mol(9.8±1.4%)。
- 在4特斯拉下进行高血糖钳夹(约12.21 mmol/l)期间用1H磁共振波谱测量脑葡萄糖变化,分别在基线和12周干预后评估。
- 12周干预通过连续葡萄糖监测、糖尿病方案强化以及频繁就诊内分泌科医生和营养师来改善血糖控制。
- 试验注册号:ClinicalTrials.gov NCT03469492。
主要发现
- 干预后平均±SD HbA1c下降24.3±15.3 mmol/mol(2.1±1.5%)(p=0.006),体重变化极小(p=0.242)。
- 采用线性混合效应回归模型比较钳夹期间葡萄糖时间曲线,干预前脑葡萄糖水平显著低于干预后(p<0.001),而钳夹期间血浆葡萄糖水平相似(p=0.266)。
- 脑葡萄糖升高与HbA1c改善幅度相关(r=0.71,p=0.048)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We have previously shown that individuals with uncontrolled type 2 diabetes have a blunted rise in brain glucose levels measured by 1H magnetic resonance spectroscopy. Here, we investigate whether reductions in HbA1c normalise intracerebral glucose levels. METHODS: Eight individuals (two men, six women) with poorly controlled type 2 diabetes and mean ± SD age 44.8 ± 8.3 years, BMI 31.4 ± 6.1 kg/m2 and HbA1c 84.1 ± 16.2 mmol/mol (9.8 ± 1.4%) underwent 1H MRS scanning at 4 Tesla during a hyperglycaemic clamp (~12.21 mmol/l) to measure changes in cerebral glucose at baseline and after a 12 week intervention that improved glycaemic control through the use of continuous glucose monitoring, diabetes regimen intensification and frequent visits to an endocrinologist and nutritionist. RESULTS: Following the intervention, mean ± SD HbA1c decreased by 24.3 ± 15.3 mmol/mol (2.1 ± 1.5%) (p=0.006), with minimal weight changes (p=0.242). Using a linear mixed-effects regression model to compare glucose time courses during the clamp pre and post intervention, the pre-intervention brain glucose level during the hyperglycaemic clamp was significantly lower than the post-intervention brain glucose (p<0.001) despite plasma glucose levels during the hyperglycaemic clamp being similar (p=0.266). Furthermore, the increases in brain glucose were correlated with the magnitude of improvement in HbA1c (r = 0.71, p=0.048). CONCLUSION/INTERPRETATION: These findings highlight the potential reversibility of cerebral glucose transport capacity and metabolism that can occur in individuals with type 2 diabetes following improvement of glycaemic control. Trial registration ClinicalTrials.gov NCT03469492.
引用
- Sanchez-Rangel E, Gunawan F, Jiang L, et al. Reversibility of brain glucose kinetics in type 2 diabetes mellitus. Diabetologia. 2022. PMID: 35247067. doi:10.1007/s00125-022-05664-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。